AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 59 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280 | -28.6% | 20,653 | -9.5% | 0.03% | -57.7% |
Q2 2023 | $392 | -24.9% | 22,832 | -11.7% | 0.07% | -1.4% |
Q1 2023 | $522 | -13.3% | 25,863 | +25.8% | 0.07% | -20.9% |
Q4 2022 | $602 | -99.8% | 20,560 | -3.7% | 0.09% | +68.5% |
Q3 2022 | $354,000 | -30.2% | 21,344 | -34.2% | 0.05% | -40.0% |
Q2 2022 | $507,000 | +15.8% | 32,414 | -12.8% | 0.09% | +20.0% |
Q4 2021 | $438,000 | -56.5% | 37,156 | -22.7% | 0.08% | -38.5% |
Q3 2021 | $1,008,000 | – | 48,059 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 603,762 | $8,193,050 | 18.42% |
TCG Crossover Management, LLC | 2,201,274 | $29,871,288 | 4.40% |
Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27,672,609 | 4.29% |
Sofinnova Investments, Inc. | 3,758,686 | $51,005,369 | 3.22% |
GREAT POINT PARTNERS LLC | 1,091,233 | $14,808,032 | 2.70% |
RA Capital Management | 8,263,982 | $112,142,236 | 2.21% |
Cormorant Asset Management, LP | 1,561,696 | $21,192,215 | 1.24% |
Frazier Life Sciences Management, L.P. | 1,204,867 | $16,350,045 | 1.09% |
Octagon Capital Advisors LP | 497,370 | $6,749,311 | 1.04% |
Ghost Tree Capital, LLC | 201,197 | $2,730,243 | 0.90% |